International Society of Liquid Biopsy (ISLB) shared on LinkedIn:
“ISLB Global Molecular Tumor Board: Gastrointestinal Cancer
Join us for the next session of the ISLB Global MTB Education Series, featuring a case-based discussion on the current role of ctDNA testing in clinical decision-making in colorectal cancer.
- Monday, October 19, 2026
- 9:00–9:30 AM EDT | 3:00–3:30 PM CEST | 9:00–9:30 PM CST
- Virtual / Zoom
Presenter and Moderator Dr. Kyaw Lwin Aung, Wertheim Cancer Institute, Miami, USA
Invited Panelists
- Prof. Michel Ducreux – Gustave Roussy, France
- Dr. Trevor Pugh – University of Toronto, Canada
- Dr. Sarbajit Mukherjee – Wertheim Cancer Institute, Miami, USA
The session will explore how ctDNA is being integrated into real-world colorectal cancer care, including its evolving role in molecular monitoring and treatment decision-making.
Bruna Pellini.”
Register for the ISLB Global MTB Education Series.
Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, added:
“How is ctDNA changing colorectal cancer care – and what can clinicians around the world learn from one another?
I’m excited to join colleagues from across the globe for this International Society of Liquid Biopsy webinar, moderated by my academic partner Kyaw Lwin Aung at WCI.
Join us for this timely discussion and let’s discuss where ctDNA is making an impact today – and where it’s headed next!”
Read more articles about ISLB and Gastrointestinal Oncology on OncoDaily.